112,904 Shares in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Bought by Raymond James Financial Inc.
Raymond James Financial Inc. purchased a new position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 112,904 shares of the company’s stock, valued at approximately $629,000. Several other institutional investors and hedge funds also recently made changes […]
Raymond James Financial Inc. purchased a new position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 112,904 shares of the company’s stock, valued at approximately $629,000. Several other institutional investors and hedge funds also recently made changes […]